A Kenyan court on Friday suspended U.S. plans to establish a quarantine facility for Americans exposed to Ebola abroad, raising questions about biosecurity protocols and the proper role of foreign health infrastructure on sovereign soil. The High Court in Nairobi halted any agreement until petitions against the facility are heard on Tuesday, following widespread opposition from medical professionals, legal advocates, and ordinary citizens concerned about public health risks and inadequate consultation.
A U.S. administration official said on Wednesday that Americans exposed to the Bundibugyo virus—a rare type of Ebola spreading in northeastern Congo—would be sent to a new facility in Kenya rather than returning home. The official spoke on condition of anonymity to share the administration's plans. It remained unclear where in Kenya the facility would be built or whether the Kenyan government had formally approved the arrangement.
Government Response and Legal Challenge
The Kenyan government acknowledged discussions with the U.S. on Ebola preparedness support but declined to confirm whether it would establish a treatment facility for Americans. Secretary of State Marco Rubio said in a statement that the U.S. government intends to commit $13.5 million toward Kenya's Ebola preparedness efforts.
Two organizations—the Katiba Institute, formed to defend Kenya's Constitution, and the Kenya Law Society—separately challenged any presence of Ebola-related facilities. The Kenya Law Society asked the court to nullify any agreements signed between the U.S. and Kenya on the project, citing public health risks and a lack of public participation. The society also argued that Kenya lacks "the high-containment infrastructure required to safely manage such a facility, exposing the public to serious health risks."
Medical Workers and Public Backlash
A Kenyan doctors' union on Thursday issued a 48-hour strike notice should the country proceed with the deal. The union noted that the U.S. was clear that they would not allow Ebola on their soil and that Kenya should not become a "dumping ground." Davji Atellah, the union's chairperson, said in a statement: "As the vanguard of Kenya's healthcare system, we are utterly disgusted by the government's apparent willingness to trade national biosecurity and the lives of its citizens for foreign aid."
Ordinary Kenyans expressed similar concerns. "Why do they want to get infected people and bring them to Kenya? Kenya is not a dumping area for such sick people," laborer Cedric Akweyu said in an interview with The Associated Press. Student Wycliff Otieno added: "It is like the government has been given a lot of money by the U.S. So, it is like they are selling us."
The Outbreak Context
In northeastern Congo, health workers with scant supplies have been struggling to contain an outbreak of the Bundibugyo virus, a kind of Ebola that has no approved treatment or vaccine. The Congolese government has confirmed more than 1,000 suspected cases, with at least 220 deaths, since it declared an outbreak on May 15. The WHO suspects the outbreak is much larger than what has been reported, as the virus had been spreading undetected for weeks. The virus also has reached neighboring Uganda, which has confirmed seven cases and one death.
Why This Matters:
The suspension highlights fundamental questions about sovereignty, public health infrastructure, and fiscal priorities. Kenya's medical professionals and legal experts have raised legitimate concerns about whether the country possesses the high-containment facilities necessary to manage infectious disease patients safely—a question of institutional capacity that transcends political considerations. The $13.5 million commitment from the U.S. government represents significant foreign aid, but critics argue that financial incentives should not override basic biosecurity requirements and public consultation. The legal challenge also underscores the importance of transparent governance and the rule of law in international agreements that affect public safety. As the Bundibugyo outbreak continues to spread in Congo with no approved treatment, the debate over where and how to manage exposed individuals raises critical questions about balancing humanitarian response with national security interests and the protection of citizens from preventable health risks.